코로나19 백신 시장 : 제품 유형, 최종 사용자, 환자 유형별 - 세계 예측(2025-2030년)

The COVID-19 Vaccines Market was valued at USD 215.43 billion in 2023, expected to reach USD 237.12 billion in 2024, and is projected to grow at a CAGR of 10.55%, to USD 434.83 billion by 2030.

The market research scope for COVID-19 vaccines encompasses the analysis of trends, market dynamics, and consumer behavior associated with vaccine development, distribution, and adoption. The necessity of these vaccines is imperative for global public health, aiming to mitigate the spread of the virus and reduce mortality rates, which directly influences economic recovery and societal well-being. The application of COVID-19 vaccines includes widespread immunization across demographic groups, addressing variants, and potential booster doses, with their end-use spanning the general public, healthcare sectors, and government and private entities. Market insights reveal key growth factors such as ongoing governmental support, a surge in public awareness, and advancements in mRNA technology that underpin vaccine innovation. However, emerging opportunities lie in expanding vaccine access to underserved regions through partnerships with international health organizations and improving supply chain logistics. These opportunities can be capitalized on by leveraging technological advancements and strategic alliances to bolster distribution networks. Limitations include vaccine hesitancy driven by misinformation, regulatory hurdles, and logistical challenges in storage and distribution, particularly in remote areas. Additionally, the virus's evolving nature and the emergence of new variants pose challenges that could alter vaccine efficacy and demand continuous research and adaptation. To navigate these challenges, businesses can innovate in areas such as vaccine storage technology, blockchain for supply chain management, and AI-driven research for adaptive vaccine formulations. The market is characterized by rapid advancements and intense competition, with players continuously seeking to enhance their offerings and expand their regional presence. Collaborations between pharmaceutical companies and tech firms could drive significant advancements in vaccine development and distribution efficiency, providing a comprehensive approach to combating COVID-19 and its evolving threats.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving COVID-19 Vaccines Market

The COVID-19 Vaccines Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rapid spread of coronavirus resulting in a large number of deaths
  • Government support and grants for COVID-19 vaccines
  • Increasing research and development (R&D) initiatives for vaccines
• Market Restraints
  • Limited supportive infrastructure, skills, and technology in developing areas around the world
• Market Opportunities
  • Growing amalgamation activities to manufacture and distribute the COVID-19 vaccines
  • Rising investments for vaccines
• Market Challenges
  • Side effects associated with the COVID-19 vaccines

Porter's Five Forces: A Strategic Tool for Navigating the COVID-19 Vaccines Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the COVID-19 Vaccines Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the COVID-19 Vaccines Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the COVID-19 Vaccines Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the COVID-19 Vaccines Market

A detailed market share analysis in the COVID-19 Vaccines Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the COVID-19 Vaccines Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the COVID-19 Vaccines Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the COVID-19 Vaccines Market

A strategic analysis of the COVID-19 Vaccines Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the COVID-19 Vaccines Market, highlighting leading vendors and their innovative profiles. These include AIVITA Biomedical Inc., AstraZeneca PLC, Baseimmune Ltd., Bharat Biotech International Ltd., Biological E. Ltd., CanSino Biologics Inc., Centivax Inc., Codagenix Inc., CureVac SE, Dr. Reddy's Laboratories Ltd., Emergex Vaccines Holding Ltd., Etherna Immunotherapies NV, Gennova Biopharmaceuticals Ltd., GlaxoSmithKline PLC, HDT Bio, Inc., Meissa Vaccines, Inc., Merck & Co., Inc., Moderna, Inc., Novavax Inc., Osivax SAS, Pfizer Inc., Providence Therapeutics Inc., SANOFI, Serum Institute of India Pvt. Ltd., Sinovac Biotech Ltd., Vaccitech PLC, and Zydus Lifesciences Ltd..

Market Segmentation & Coverage

This research report categorizes the COVID-19 Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Type, market is studied across Monovalent Vaccine and Multivalent Vaccine.
• Based on End-User, market is studied across Academic & Research Centers, Clinics, Hospitals, and Vaccination Centers.
• Based on Patient Type, market is studied across Adult, Pediatric, and Senior Citizens.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rapid spread of coronavirus resulting in a large number of deaths
    • 5.1.1.2. Government support and grants for COVID-19 vaccines
    • 5.1.1.3. Increasing research and development (R&D) initiatives for vaccines
  • 5.1.2. Restraints
    • 5.1.2.1. Limited supportive infrastructure, skills, and technology in developing areas around the world
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing amalgamation activities to manufacture and distribute the COVID-19 vaccines
    • 5.1.3.2. Rising investments for vaccines
  • 5.1.4. Challenges
    • 5.1.4.1. Side effects associated with the COVID-19 vaccines
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. COVID-19 Vaccines Market, by Product Type

• 6.1. Introduction
• 6.2. Monovalent Vaccine
• 6.3. Multivalent Vaccine

7. COVID-19 Vaccines Market, by End-User

• 7.1. Introduction
• 7.2. Academic & Research Centers
• 7.3. Clinics
• 7.4. Hospitals
• 7.5. Vaccination Centers

8. COVID-19 Vaccines Market, by Patient Type

• 8.1. Introduction
• 8.2. Adult
• 8.3. Pediatric
• 8.4. Senior Citizens

9. Americas COVID-19 Vaccines Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific COVID-19 Vaccines Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa COVID-19 Vaccines Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AIVITA Biomedical Inc.
• 2. AstraZeneca PLC
• 3. Baseimmune Ltd.
• 4. Bharat Biotech International Ltd.
• 5. Biological E. Ltd.
• 6. CanSino Biologics Inc.
• 7. Centivax Inc.
• 8. Codagenix Inc.
• 9. CureVac SE
• 10. Dr. Reddy's Laboratories Ltd.
• 11. Emergex Vaccines Holding Ltd.
• 12. Etherna Immunotherapies NV
• 13. Gennova Biopharmaceuticals Ltd.
• 14. GlaxoSmithKline PLC
• 15. HDT Bio, Inc.
• 16. Meissa Vaccines, Inc.
• 17. Merck & Co., Inc.
• 18. Moderna, Inc.
• 19. Novavax Inc.
• 20. Osivax SAS
• 21. Pfizer Inc.
• 22. Providence Therapeutics Inc.
• 23. SANOFI
• 24. Serum Institute of India Pvt. Ltd.
• 25. Sinovac Biotech Ltd.
• 26. Vaccitech PLC
• 27. Zydus Lifesciences Ltd.